Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes

Nicotinamide adenine dinucleotide (NAD+) -dependent protein deacetylase SIRT1 plays an important role in the regulation of metabolism. Although the administration of nicotinamide mononucleotide (NMN), a key NAD+ intermediate, has been shown to ameliorate metabolic disorders, such as insulin resistan...

Full description

Bibliographic Details
Main Authors: Yukiko Imi, Reina Amano, Nanaho Kasahara, Yuichiro Obana, Tetsuya Hosooka
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580823000572
_version_ 1797813722644742144
author Yukiko Imi
Reina Amano
Nanaho Kasahara
Yuichiro Obana
Tetsuya Hosooka
author_facet Yukiko Imi
Reina Amano
Nanaho Kasahara
Yuichiro Obana
Tetsuya Hosooka
author_sort Yukiko Imi
collection DOAJ
description Nicotinamide adenine dinucleotide (NAD+) -dependent protein deacetylase SIRT1 plays an important role in the regulation of metabolism. Although the administration of nicotinamide mononucleotide (NMN), a key NAD+ intermediate, has been shown to ameliorate metabolic disorders, such as insulin resistance and glucose intolerance, the direct effect of NMN on the regulation of lipid metabolism in adipocytes remains unclear. We here investigated the effect of NMN on lipid storage in 3T3-L1 differentiated adipocytes. Oil-red O staining showed that NMN treatment reduced lipid accumulation in these cells. NMN was found to enhance lipolysis in adipocytes since the concentration of glycerol in the media was increased by NMN treatment. Western blotting and real-time RT-PCR analysis revealed that adipose triglyceride lipase (ATGL) expression at both protein and mRNA level was increased with NMN treatment in 3T3-L1 adipocytes. Whereas NMN increased SIRT1 expression and AMPK activation, an AMPK inhibitor compound C restored the NMN-dependent upregulation of ATGL expression in these cells, suggesting that NMN upregulates ATGL expression through the SIRT1-AMPK axis. NMN administration significantly decreased subcutaneous fat mass in mice on a high-fat diet. We also found that adipocyte size in subcutaneous fat was decreased with NMN treatment. Consistent with the alteration of fat mass and adipocyte size, the ATGL expression in subcutaneous fat was slightly, albeit significantly, increased with NMN treatment. These results indicate that NMN suppresses subcutaneous fat mass in diet-induced obese mice, potentially in part via the upregulation of ATGL. Unexpectedly, the reduction in fat mass as well as ATGL upregulation with NMN treatment were not observed in epididymal fat, implying that the effects of NMN are site-specific in adipose tissue. Thus, these findings provide important insights into the mechanism of NMN/NAD+ in the regulation of metabolism.
first_indexed 2024-03-13T07:56:57Z
format Article
id doaj.art-48b868583a5447dcab01270e54e812d2
institution Directory Open Access Journal
issn 2405-5808
language English
last_indexed 2024-03-13T07:56:57Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj.art-48b868583a5447dcab01270e54e812d22023-06-02T04:23:27ZengElsevierBiochemistry and Biophysics Reports2405-58082023-07-0134101476Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytesYukiko Imi0Reina Amano1Nanaho Kasahara2Yuichiro Obana3Tetsuya Hosooka4Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, 422-8526, JapanGraduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, 422-8526, JapanGraduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, 422-8526, JapanGraduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, 422-8526, JapanCorresponding author.; Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, 422-8526, JapanNicotinamide adenine dinucleotide (NAD+) -dependent protein deacetylase SIRT1 plays an important role in the regulation of metabolism. Although the administration of nicotinamide mononucleotide (NMN), a key NAD+ intermediate, has been shown to ameliorate metabolic disorders, such as insulin resistance and glucose intolerance, the direct effect of NMN on the regulation of lipid metabolism in adipocytes remains unclear. We here investigated the effect of NMN on lipid storage in 3T3-L1 differentiated adipocytes. Oil-red O staining showed that NMN treatment reduced lipid accumulation in these cells. NMN was found to enhance lipolysis in adipocytes since the concentration of glycerol in the media was increased by NMN treatment. Western blotting and real-time RT-PCR analysis revealed that adipose triglyceride lipase (ATGL) expression at both protein and mRNA level was increased with NMN treatment in 3T3-L1 adipocytes. Whereas NMN increased SIRT1 expression and AMPK activation, an AMPK inhibitor compound C restored the NMN-dependent upregulation of ATGL expression in these cells, suggesting that NMN upregulates ATGL expression through the SIRT1-AMPK axis. NMN administration significantly decreased subcutaneous fat mass in mice on a high-fat diet. We also found that adipocyte size in subcutaneous fat was decreased with NMN treatment. Consistent with the alteration of fat mass and adipocyte size, the ATGL expression in subcutaneous fat was slightly, albeit significantly, increased with NMN treatment. These results indicate that NMN suppresses subcutaneous fat mass in diet-induced obese mice, potentially in part via the upregulation of ATGL. Unexpectedly, the reduction in fat mass as well as ATGL upregulation with NMN treatment were not observed in epididymal fat, implying that the effects of NMN are site-specific in adipose tissue. Thus, these findings provide important insights into the mechanism of NMN/NAD+ in the regulation of metabolism.http://www.sciencedirect.com/science/article/pii/S2405580823000572Nicotinamide mononucleotideAdipose triglyceride lipase3T3-L1 adipocytesWhite adipose tissueMice
spellingShingle Yukiko Imi
Reina Amano
Nanaho Kasahara
Yuichiro Obana
Tetsuya Hosooka
Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
Biochemistry and Biophysics Reports
Nicotinamide mononucleotide
Adipose triglyceride lipase
3T3-L1 adipocytes
White adipose tissue
Mice
title Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
title_full Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
title_fullStr Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
title_full_unstemmed Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
title_short Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
title_sort nicotinamide mononucleotide induces lipolysis by regulating atgl expression via the sirt1 ampk axis in adipocytes
topic Nicotinamide mononucleotide
Adipose triglyceride lipase
3T3-L1 adipocytes
White adipose tissue
Mice
url http://www.sciencedirect.com/science/article/pii/S2405580823000572
work_keys_str_mv AT yukikoimi nicotinamidemononucleotideinduceslipolysisbyregulatingatglexpressionviathesirt1ampkaxisinadipocytes
AT reinaamano nicotinamidemononucleotideinduceslipolysisbyregulatingatglexpressionviathesirt1ampkaxisinadipocytes
AT nanahokasahara nicotinamidemononucleotideinduceslipolysisbyregulatingatglexpressionviathesirt1ampkaxisinadipocytes
AT yuichiroobana nicotinamidemononucleotideinduceslipolysisbyregulatingatglexpressionviathesirt1ampkaxisinadipocytes
AT tetsuyahosooka nicotinamidemononucleotideinduceslipolysisbyregulatingatglexpressionviathesirt1ampkaxisinadipocytes